| Primary |
| Hormone Replacement Therapy |
30.0% |
| Menopausal Symptoms |
26.7% |
| Oestradiol Decreased |
13.3% |
| Bladder Disorder |
6.7% |
| Hysterectomy |
6.7% |
| Vulvovaginal Dryness |
6.7% |
| Artificial Menopause |
3.3% |
| Menopausal Disorder |
3.3% |
| Thyroid Disorder |
3.3% |
|
| Breast Cancer |
40.0% |
| Ovarian Cancer |
14.3% |
| Convulsion |
2.9% |
| Drug Ineffective |
2.9% |
| Hyperhidrosis |
2.9% |
| Lupus-like Syndrome |
2.9% |
| Medication Error |
2.9% |
| Metastases To Lymph Nodes |
2.9% |
| Myalgia |
2.9% |
| Myocardial Infarction |
2.9% |
| Neoplasm Progression |
2.9% |
| Progesterone Receptor Assay Positive |
2.9% |
| Rash |
2.9% |
| Stomach Discomfort |
2.9% |
| Thrombosis |
2.9% |
| Vaginal Haemorrhage |
2.9% |
| Vision Blurred |
2.9% |
| Wrong Technique In Drug Usage Process |
2.9% |
|
| Secondary |
| Hormone Replacement Therapy |
87.1% |
| Menopausal Symptoms |
6.8% |
| Menopause |
1.5% |
| Hot Flush |
0.9% |
| Ill-defined Disorder |
0.8% |
| Drug Use For Unknown Indication |
0.5% |
| Oestrogen Replacement Therapy |
0.4% |
| Hormone Therapy |
0.3% |
| Hypertension |
0.3% |
| Anxiety |
0.2% |
| Diabetes Mellitus |
0.2% |
| Depression |
0.1% |
| Fibromyalgia |
0.1% |
| Multiple Sclerosis |
0.1% |
| Product Used For Unknown Indication |
0.1% |
| Thyroid Disorder |
0.1% |
| Ankylosing Spondylitis |
0.1% |
| Bladder Disorder |
0.1% |
| Bladder Spasm |
0.1% |
| Diuretic Therapy |
0.1% |
|
| Breast Cancer Female |
42.6% |
| Breast Cancer |
35.4% |
| Breast Cancer Metastatic |
5.4% |
| Breast Disorder |
2.5% |
| Ovarian Cancer |
1.8% |
| Thrombosis |
1.8% |
| Invasive Ductal Breast Carcinoma |
1.1% |
| Ovarian Cancer Metastatic |
1.1% |
| Progesterone Receptor Assay Positive |
1.1% |
| Breast Cancer In Situ |
0.7% |
| Contralateral Breast Cancer |
0.7% |
| Gallbladder Disorder |
0.7% |
| Irritability |
0.7% |
| Myocardial Infarction |
0.7% |
| Oestrogen Receptor Assay Positive |
0.7% |
| Paget's Disease Of The Breast |
0.7% |
| Venous Thrombosis |
0.7% |
| Vision Blurred |
0.7% |
| Cardiac Disorder |
0.4% |
| Cerebrovascular Accident |
0.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.9% |
| Drug Use For Unknown Indication |
8.7% |
| Depression |
6.3% |
| Pain |
5.2% |
| Cardiac Disorder |
5.1% |
| Rheumatoid Arthritis |
4.7% |
| Hypertension |
4.4% |
| Gastrooesophageal Reflux Disease |
4.2% |
| Hormone Replacement Therapy |
4.1% |
| Smoking Cessation Therapy |
3.5% |
| Blood Pressure |
3.0% |
| Hormone Therapy |
2.8% |
| Multiple Sclerosis |
2.8% |
| Osteoporosis |
2.8% |
| Anxiety |
2.7% |
| Arthritis |
2.5% |
| Chest Pain |
2.5% |
| Fibromyalgia |
1.9% |
| Sleep Disorder |
1.9% |
| Diabetes Mellitus |
1.8% |
|
| Weight Increased |
17.9% |
| Vision Blurred |
10.4% |
| Vomiting |
8.2% |
| Weight Decreased |
6.7% |
| Nausea |
5.2% |
| Restless Legs Syndrome |
5.2% |
| Drug Ineffective |
4.5% |
| Pain |
4.5% |
| Urticaria |
4.5% |
| Insomnia |
3.7% |
| Myocardial Infarction |
3.7% |
| Somnolence |
3.7% |
| Pain In Extremity |
3.0% |
| Sinusitis |
3.0% |
| Speech Disorder |
3.0% |
| Squamous Cell Carcinoma |
3.0% |
| Tendon Rupture |
3.0% |
| Cardiac Failure |
2.2% |
| Coronary Artery Disease |
2.2% |
| Drug Dose Omission |
2.2% |
|
